Search - tctmd.com

Displaying 221 - 240 of 318

Sort: Relevancy | Date

News Industry News

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

October 14, 2015

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Industry News

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

Yael L. Maxwell

October 11, 2015

News Daily News

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

Todd Neale

October 08, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Industry News

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

September 01, 2015

News Daily News

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Todd Neale

August 31, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

透析是 CLI 血管内介入治疗后结局不良的关键预测因素

L.A. McKeown

August 05, 2015

News Daily News

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

L.A. McKeown

August 05, 2015

News Daily News

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

L.A. McKeown

August 05, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

Advertisement

Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

PANDA III: BuMA SES Noninferior to Excel SES for TLF at 1 Year

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

Novel Devices Present New Treatment Options for STEMI

Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

ABSORB Trials Pit BRS Against Second-Generation DES

Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

透析是 CLI 血管内介入治疗后结局不良的关键预测因素

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content